Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

cra international inc - CRAI

CRAI

Close Chg Chg %
207.85 -3.33 -1.60%

Closed Market

204.52

-3.33 (1.60%)

Volume: 129.39K

Last Updated:

Dec 30, 2025, 4:00 PM EDT

Trade Now

Company Overview: cra international inc - CRAI

CRAI Key Data

Open

$207.83

 Day Range

204.39 - 209.12

52 Week Range

152.57 - 215.03

 Market Cap

$1.36B

Shares Outstanding

6.56M

 Public Float

6.30M

Beta

0.92

 Rev. Per Employee

N/A

P/E Ratio

24.80

 EPS

$8.43

Yield

98.91%

 Dividend

$0.57

EX-DIVIDEND DATE

Nov 25, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

99.37K

  

CRAI Performance

1 Week
 
 -0.83%
 
1 Month
 
 15.98%
 
3 Months
 
 4.43%
 
1 Year
 
 9.25%
 
5 Years
 
 301.57%
 

CRAI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About cra international inc - CRAI

CRA International, Inc. is a consulting firm, which engages in the provision of economic, financial, and management consulting services. It offers consulting services through the litigation, regulatory, financial, and management consulting areas. The company was founded by Jerry Kraft, Alan Willens, and John Kaler in February 1965 and is headquartered in Boston, MA.

CRAI At a Glance

CRA International, Inc.
200 Clarendon Street
Boston, Massachusetts 02116-5092
Phone 1-617-425-3000 Revenue 687.41M
Industry Miscellaneous Commercial Services Net Income 46.53M
Sector Commercial Services 2024 Sales Growth 10.167%
Fiscal Year-end 12 / 2025 Employees 946
View SEC Filings

CRAI Valuation

P/E Current 24.80
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 27.741
Price to Sales Ratio 1.878
Price to Book Ratio 5.963
Price to Cash Flow Ratio 25.95
Enterprise Value to EBITDA 14.039
Enterprise Value to Sales 1.989
Total Debt to Enterprise Value 0.076

CRAI Efficiency

Revenue/Employee 726,653.277
Income Per Employee 49,181.818
Receivables Turnover 3.041
Total Asset Turnover 1.222

CRAI Liquidity

Current Ratio 1.072
Quick Ratio 1.072
Cash Ratio 0.106

CRAI Profitability

Gross Margin 28.456
Operating Margin 10.265
Pretax Margin 9.636
Net Margin 6.768
Return on Assets 8.274
Return on Equity 21.937
Return on Total Capital 14.756
Return on Invested Capital 15.483

CRAI Capital Structure

Total Debt to Total Equity 48.68
Total Debt to Total Capital 32.741
Total Debt to Total Assets 18.066
Long-Term Debt to Equity 39.864
Long-Term Debt to Total Capital 26.812
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cra International Inc - CRAI

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
565.93M 590.90M 623.98M 687.41M
Sales Growth
+11.32% +4.41% +5.60% +10.17%
Cost of Goods Sold (COGS) incl D&A
412.82M 422.08M 452.25M 491.80M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
25.78M 25.75M 25.84M 26.82M
Depreciation
24.88M 24.55M 24.44M 25.32M
Amortization of Intangibles
900.00K 1.20M 1.40M 1.50M
COGS Growth
+7.96% +2.24% +7.15% +8.75%
Gross Income
153.11M 168.82M 171.73M 195.61M
Gross Income Growth
+21.54% +10.26% +1.72% +13.91%
Gross Profit Margin
+27.05% +28.57% +27.52% +28.46%
2021 2022 2023 2024 5-year trend
SG&A Expense
97.37M 110.09M 115.12M 125.05M
Research & Development
- - - -
-
Other SG&A
97.37M 110.09M 115.12M 125.05M
SGA Growth
+8.16% +13.06% +4.57% +8.63%
Other Operating Expense
- - - -
-
Unusual Expense
- - (934.00K) (190.00K)
-
EBIT after Unusual Expense
55.74M 58.74M 57.54M 70.75M
Non Operating Income/Expense
(494.00K) 1.89M (1.45M) (92.00K)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
970.00K 1.83M 3.81M 4.42M
Interest Expense Growth
-20.23% +88.25% +108.76% +15.87%
Gross Interest Expense
970.00K 1.83M 3.81M 4.42M
Interest Capitalized
- - - -
-
Pretax Income
54.27M 58.80M 52.29M 66.24M
Pretax Income Growth
+61.43% +8.34% -11.07% +26.69%
Pretax Margin
+9.59% +9.95% +8.38% +9.64%
Income Tax
12.60M 15.18M 13.81M 19.59M
Income Tax - Current - Domestic
9.63M 12.04M 15.64M 18.50M
Income Tax - Current - Foreign
2.52M 2.96M 2.80M 3.96M
Income Tax - Deferred - Domestic
216.00K 75.00K (3.59M) (3.01M)
Income Tax - Deferred - Foreign
230.00K 114.00K (1.04M) 146.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(175.00K) (167.00K) (136.00K) (127.00K)
Consolidated Net Income
41.50M 43.45M 38.34M 46.53M
Minority Interest Expense
- - - -
-
Net Income
41.50M 43.45M 38.34M 46.53M
Net Income Growth
+70.00% +4.69% -11.75% +21.34%
Net Margin Growth
+7.33% +7.35% +6.15% +6.77%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
41.50M 43.45M 38.34M 46.53M
Preferred Dividends
- - - -
-
Net Income Available to Common
41.50M 43.45M 38.34M 46.53M
EPS (Basic)
5.5913 6.02 5.4716 6.821
EPS (Basic) Growth
+77.90% +7.67% -9.11% +24.66%
Basic Shares Outstanding
7.42M 7.22M 7.01M 6.82M
EPS (Diluted)
5.446 5.9078 5.387 6.7351
EPS (Diluted) Growth
+77.30% +8.48% -8.82% +25.03%
Diluted Shares Outstanding
7.62M 7.36M 7.12M 6.91M
EBITDA
81.52M 84.49M 82.45M 97.39M
EBITDA Growth
+34.01% +3.64% -2.41% +18.12%
EBITDA Margin
+14.40% +14.30% +13.21% +14.17%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 247.50
Number of Ratings 2 Current Quarters Estimate 2.068
FY Report Date 12 / 2025 Current Year's Estimate 8.241
Last Quarter’s Earnings 2.06 Median PE on CY Estimate N/A
Year Ago Earnings 7.60 Next Fiscal Year Estimate 8.906
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 2 3 3
Mean Estimate 2.07 2.25 8.24 8.91
High Estimates 2.15 2.41 8.32 9.00
Low Estimate 1.98 2.10 8.15 8.83
Coefficient of Variance 3.99 9.59 1.01 0.95

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Cra International Inc - CRAI

Date Name Shares Transaction Value
Jul 29, 2025 Heather E. Tookes Director 3,051 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $177.03 per share 540,118.53
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 4,624 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 19,720 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 19,718 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $172.33 per share 3,398,002.94
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 19,719 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 19,718 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $172.33 per share 3,398,002.94
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 397 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 396 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2025 Jonathan D. Yellin EVP AND GENERAL COUNSEL 571 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 5,724 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 5,410 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 144,388 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 4,135 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 2,297 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 2,803 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 2,811 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 1,947 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 1,952 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 144,382 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $172.33 per share 24,881,350.06
Mar 21, 2025 Paul Abraham Maleh PRESIDENT AND CEO; Director 144,390 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Cra International Inc in the News